David Efraim Rosen, 10% Owner at TherapeuticsMD, Inc. (TXMD), bought 15,000 shares at $0.82 ($12K) on 2022-07-29, disclosed to the SEC on 2022-08-01.
Open-market purchase of $12k TXMD by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| TXMD | BUY | 2022-12-09 | $229K | — | Filing → |
| TXMD | BUY | 2022-08-01 | $2.7M | — | Filing → |
| TXMD | BUY | 2022-07-19 | $935K | — | Filing → |